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Human immunodeficiency virus type 1 (HIV-1) coinfection decreases antibodies to variant surface antigens
implicated in pregnancy-associated malaria (VSA-PAM) caused by Plasmodium falciparum. The effect of HIV-1
on antibody functions that may protect mothers from pregnancy-associated malaria is unknown. Sera from
multigravid pregnant women with malaria and HIV-1 coinfection (n  58) or malaria alone (n  29) and from
HIV-1-infected (n  102) or -uninfected (n  54) multigravidae without malaria were analyzed for anti-VSA-
PAM antibodies by flow cytometry, the ability to inhibit adhesion to chondroitin sulfate A, or to opsonize
CS2-infected erythrocytes for phagocytosis by THP-1 cells. In women with malaria, anti-VSA-PAM levels
correlated better with opsonic activity (r  0.60) than with adhesion-blocking activity (r  0.33). In univariate
analysis, HIV-1 coinfection was associated with lower opsonic activity but not adhesion-blocking activity or
anti-VSA-PAM levels. Malaria-infected women with anemia (hemoglobin levels of <11.0 g/dl) had lower
opsonic activity than nonanemic women (P  0.007) independent of HIV-1 status. By multivariate analysis, in
malaria-infected women, anemia (but not HIV status) was associated with opsonic activity. In women without
malaria, opsonic activity was not associated with either anemia or HIV-1 status. In multigravid pregnant
women with malaria, impaired serum opsonic activity may contribute to anemia and possibly to the decreased
immunity to pregnancy-associated malaria associated with HIV-1.
Inhabitants of regions where malaria is endemic usually de-
velop protective immunity to malaria by adolescence; however,
protection is partially abrogated in women during pregnancy
(19), resulting in pregnancy-associated malaria (PAM). Ap-
proximately 25 million women fall pregnant in sub-Saharan
Africa every year, many in regions where both Plasmodium
falciparum malaria and human immunodeficiency virus type 1
(HIV-1) infections are endemic (31). HIV-1 infection signifi-
cantly increases the prevalence and density of malaria infection
in pregnant women (reviewed in reference 31; 22).
P. falciparum-infected erythrocytes (IE) express variant sur-
face antigens (VSA) on their surface (16), which mediate ad-
hesion to host receptors and which are major targets of the
immune response (4). The clearance of IE is presumed to be
mediated by antibodies specific for VSA, which may block
adhesion and/or facilitate opsonic clearance by phagocytes. A
unique subset of VSA, termed VSA-PAM, is expressed by
malaria strains isolated from pregnant women and mediates
the placental adhesion of IE via binding to chondroitin sulfate
A (CSA) (9, 24, 27) and other ligands (3). Antibodies against
VSA-PAM are generated in a gravidity-dependent manner
(23, 27) and are associated with protection against PAM.
HIV-coinfected women have significantly lower anti-VSA-
PAM antibody levels than HIV-uninfected women, and these
antibodies are decreased in a CD4 T-cell-dependent manner
(20). The impairment of anti-PAM immunity does not appear
to be part of a general effect of HIV infection on humoral
immunity to malaria since antibody responses to most other
malaria antigens studied to date are not impaired (1, 20). HIV
coinfection impairs immunity to PAM in women of all gravid-
ities. The effect of HIV on levels of total immunoglobulin G to
VSA-PAM is greatest in primigravid women (20), but the rel-
ative risk of contracting malaria for HIV-infected women com-
pared to HIV-uninfected women appears to increase with gra-
vidity (31). We postulate that specific functional defects in
antibody responses may be more relevant to an understanding
of the impact of HIV infection on susceptibility to malaria and
that the presence of such defects in HIV-infected multigravid
women might explain their increased susceptibility to malaria.
We therefore measured IgG antibodies recognizing VSA-
PAM, antibody-dependent inhibition of adhesion to CSA, and
opsonic activity against IE expressing VSA-PAM in sera ob-
tained from pregnant multigravid women with and without
HIV coinfection.
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(This work was presented in part at the 56th Annual Meet-
ing of the American Society of Tropical Medicine and Hy-
giene, Philadelphia, PA [25a].)
MATERIALS AND METHODS
Study sample. Patient sera were collected as previously described (20). Blood
was obtained in the third trimester of pregnancy from women admitted to the
Queen Elizabeth Central Hospital in Blantyre, Malawi, between December 2000
and April 2004 after written, informed consent was obtained for HIV counseling
and testing and after testing for malaria infection. During pregnancy, over 90%
of women had taken one or more treatment courses of intermittent preventive
sulfadoxine-pyrimethamine treatment (median, 2; range, 1 to 5). The hemoglo-
bin (Hb) concentration was measured using a Coulter counter or (when this was
unavailable) a Hemocue hemoglobinometer, and anemia was defined as an Hb
concentration below 11.0 g/dl. Malaria infection was defined as the presence of
IE upon examination of Giemsa-stained histological sections of placenta (21).
Placental malaria infection was examined and staged as previously described (26),
with stage 1 being parasites only, stage 2 being parasites plus pigmented leuko-
cytes with or without malaria pigment in fibrin, stage 3 being parasites and
malaria pigment in fibrin only, stage 4 being malaria pigment in fibrin only, and
stage 5 being no infection. Sera were stored at 70°C before and after heat
inactivation (56°C for 1 h) and transported to Australia in liquid nitrogen (20).
The present study involved the testing 87 sera from multigravid women with
placental malaria, 29 of whom were HIV uninfected and 58 of whom were HIV
infected, and 156 sera from multigravid pregnant women without malaria, 54 of
whom were HIV uninfected and 102 of whom were HIV infected. All available
sera from each group were tested. In addition, we examined serum samples from
44 primigravid women with placental malaria and without HIV infection and 14
sympatric men as negative controls (provided by Terrie Taylor, collected with
informed consent from fathers of children admitted to the hospital with malaria).
Age, Hb levels, CD4 T-cell count (measured by FACScan; Becton Dickinson),
and birth weight data for the multigravid women are presented in Table 1.
HIV-infected women gave birth to lighter babies in both the malaria-infected (on
average, 258 g lighter; 2,832  69.88 g versus 3,090  77.45 g; P  0.036) and
malaria-uninfected (on average, 250 g lighter; 2,956  62.34 g versus 3,206 
76.40 g; P  0.017) cohorts. HIV infection was associated with a significantly
lower Hb level in women without malaria but not in women with malaria coin-
fection. There was no significant difference in age between any of the groups of
women, and malaria status was not associated with any difference in CD4 counts
among HIV-infected women.
Ethical approval. The study was approved by the College of Medicine Re-
search Ethics Committee, University of Malawi, and by the Human Research
Ethics Committee, Melbourne Health, Melbourne, Australia.
Production of CSA-binding CS2 parasites. The P. falciparum parasite line CS2
(6) was cultured in unexpired human group O erythrocytes provided by the
Australian Red Cross Blood Service. Cells were maintained at 1 to 12% para-
sitemia in RPMI-HEPES supplemented with 0.5% Albumax II, 50 g/ml hypo-
xanthine, 2.5 g/ml gentamicin, and 25 mM NaHCO3 (supplemented RPMI-
HEPES). Adhesion to CSA was regularly checked and remained at a constant
high level. Cultures were synchronized by gelatin flotation every 1 to 2 weeks.
Purification of parasitized erythrocytes. Trophozoite-stage parasites were pu-
rified by Percoll (Amersham, Rydalmere, NSW, Australia) density gradient cen-
trifugation using layers of 80%, 60%, and 40% Percoll in supplemented RPMI-
HEPES. After centrifugation at 2,095  g for 15 min, collection of the 60% layer
yielded 80 to 95% pure preparations of CS2 IE, which were washed three times
and resuspended in culture medium. IE were used for measurements of phago-
cytosis or antiadhesion assays within 3 h of preparation.
Flow cytometry. Cultures of 5 to 10% IE were used to test sera for total IgG
to VSA-PAM as described previously (20), with minor modifications. IE (0.1%
hematocrit) were incubated with individual patient serum diluted at 1:20 in 1%
fetal calf serum (FCS) in phosphate-buffered saline (PBS). After 30 min, IE were
washed three times and incubated for 30 min with rabbit anti-human IgG (1:100;
Dako, Botany, NSW, Australia), followed by donkey anti-rabbit IgG conjugated
to Alexa Fluor 488 (1:500; Molecular Probes, Mount Waverley, VIC, Australia)
plus 10 g/ml ethidium bromide in PBS with 1% FCS. Samples were analyzed on
a Becton Dickinson FACSCalibur flow cytometer. One thousand IE were
counted, and the geometric mean fluorescence intensity for Alexa Fluor 488 was
calculated as a measure of IgG binding to IE. Positive and negative controls
comprising pooled sera from malaria-exposed pregnant women and sera from
individual malaria-naïve Melbourne blood donors were analyzed in each assay
for standardization, and antibody levels were expressed relative to controls as
described previously (20). The positive-control standard serum was generated by
mixing equal volumes of sera from 46 pregnant Malawian women previously
shown to have high levels of reactivity against the CS2 parasite line by flow
cytometry. Fifteen sera were obtained from HIV-infected multigravidae, and 31
sera were obtained from HIV-uninfected women (4 primigravid, 13 secundi-
gravid, and 14 multigravid women). The same pooled positive-control patient
serum was used in adhesion inhibition and opsonic activity assays described
below.
Adhesion inhibition assays. Sera were tested for the ability to inhibit the
adhesion of IE via our previously reported methods (2), with minor modifica-
tions. Bovine tracheal CSA (10 g/ml; Sigma, Castle Hill, NSW, Australia) in
PBS was coated in 10-l droplets onto 150-mm petri dishes (Becton-Dickinson,
North Ryde, NSW, Australia) overnight. The droplet location was marked on the
undersurface of the dish, and wells 10 mm in diameter were then created around
the dried CSA spots using a wax pen for immunohistochemistry (Dako). Wells
were blocked with 10% nonimmune human serum in supplemented RPMI-
HEPES for 30 min. IE (6 to 10% parasitemia; 0.5% hematocrit) were washed
and incubated in supplemented RPMI-HEPES (pH 6.8) with test and control
sera at a 1-in-10 dilution in microcentrifuge tubes for 30 min at 37°C. After
resuspension, 15 l of IE was added to triplicate wells (prepared as described
above), and the plate was incubated for 15 to 20 min at 37°C. Plates were
carefully washed with supplemented RPMI-HEPES to remove unbound cells.
Bound cells were fixed with 2% glutaraldehyde in PBS for a minimum of 2 h,
stained with Giemsa for 10 min, dried, and counted by microscopy. Pooled
patient serum was used as a positive control, as described above. Percent adhe-
sion inhibition was determined relative to the positive control using the formula
(sample/positive control)  100.
Cell culture. THP1 cells were cultured in RPMI 1640 medium supplemented
with 10% FCS, 2 mM L-glutamine, and 24 g/ml gentamicin (supplemented
RPMI). Cells were passaged every 2 to 3 days by centrifugation (600  g for 5
min), with subsequent resuspension at 2  104 to 4  104 viable cells/ml. Cell
density was kept below 1  106 viable cells/ml at all times, and cultures were
discarded after passages 12 to 15. Cells were resuspended at a concentration of
1  106 cells/ml, seeded at 5  104 cells/well in a 96-well plate, and then induced
to differentiate into adherent monocytic cells by the addition of 20 nM phorbol
myristate acetate for 2 to 3 days before being used in phagocytosis assays.
Colorimetric phagocytosis assay. A phagocytic assay employing PMA-differ-
entiated THP1 cells (13, 28, 30) was modified to include colorimetric quantita-
tion of internalized IE. The phagocytosis assay was performed as described
previously (5), with minor modifications. CS2 IE were washed in cold PBS (900  g
for 2 min at 4°C) in fetal calf serum-coated Eppendorf tubes before opsonization
TABLE 1. Age, child’s birth weight, and relevant clinical data for the cohorts of multigravid pregnant women participating in this studya
Group Mean age (yr) (SEM)(no. of women)
Mean Hb level (g/dl)
(SEM) (no. of
women)






M H 26.96 (0.4414) (57) 10.35 (0.2396) (58) 2,832* (69.88) (55) 340.3 (26.27) (55)
M H 28.10 (1.010) (29) 10.84 (0.3041) (29) 3,090* (77.45) (22) NA
M H 28.79 (0.4481) (102) 10.93† (0.1831) (99) 2,956** (62.34) (97) 360.1 (24.14) (90)
M H 28.50 (0.6602) (54) 12.21† (0.2299) (54) 3,206** (76.40) (49) NA
a Data represent means (standard errors of the means) and the numbers of each cohort of each respective measurement. M, malaria infected; M, malaria
uninfected; H, HIV infected; H, HIV uninfected; NA, not applicable. For birth weight, P values were 0.036 () and 0.017 () by an unpaired t test. For Hb, the
P value was 0.0001 (†) by an unpaired t test.
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at 1  108 cells/ml with 9% (vol/vol) patient sera for 1 h at room temperature.
CS2 IE were also opsonized with a single batch of pooled patient sera as a
positive control and internal standard against which individual patient samples
were normalized (see above for details of the positive-control, pooled sera).
Following opsonization, CS2 IE were washed in cold PBS and resuspended at 1 
108 cells/ml. Opsonized and unopsonized CS2 IE were added to THP1 cells
(quadruplicate wells of a 96-well plate for each serum sample seeded with 50,000
cells per well in 200 l of supplemented RPMI) at a ratio of 20 parasites per
THP1 cell and then incubated for 2 h at 37°C to allow phagocytosis. After
incubation, phagocytosis was stopped by the addition of 100 l cold PBS, aspi-
rating the PBS, and 100 l of 0.2% NaCl was then added for 3 min to lyse
uningested erythrocytes. Lysed erythrocytes were removed by four 200-l washes
with warm supplemented RPMI, and ingested Hb was then released by lysing the
THP1 cells using 100 l 0.2 M Tris-HCl containing 6 M urea for 30 min. Hb was
quantified by reactions with 100 l of freshly made 2,7-diaminofluorene (DAF)
solution (1-ml stock of 10 mg/ml DAF [Sigma] dissolved in 90% acetic acid, 0.1
ml 30% hydrogen peroxide, and 8.9 ml 6 M urea), and the colored reaction
product was measured at 620 nm and quantified by reference to a standard curve
of unopsonized IE derived from the same culture. The standard curve was
constructed by making seven serial twofold dilutions of IE (2.5  107 to 3.91 
105 cells/ml plus a zero-erythrocyte control in PBS) and adding 10 l of each
dilution to triplicate wells reserved on the assay plate. Standards were lysed in
100 l of 0.2 M Tris-HCl containing 6 M urea and reacted with DAF as described
above for the phagocytosis samples. The absorbance obtained for each phago-
cytosis well was converted to an equivalent number of ingested erythrocytes by
reference to the standard curve and then to a phagocytic index by dividing by the
number of THP-1 cells seeded (5  104 cells) and multiplying by 100. The
opsonic activity of individual sera was defined as the phagocytic index obtained
using IE opsonized with each serum sample divided by the phagocytic index
obtained with the pooled patient reference serum analyzed on the same plate,
multiplied by 100.
Statistical methods. Distribution analysis showed that neither adhesion-block-
ing nor opsonic activity was normally distributed in these patient cohorts. Data
for both assays were therefore normalized using log10 transformation prior to
analysis, and parametric statistics were used to compare log-transformed data
between groups. Univariate analysis, using t tests and applying Bonferroni’s
correction for multiple comparisons where appropriate, was used to investigate
statistically significant differences in antibody levels or functions in relation to
patient characteristics. Logistic regression analysis was used for estimating pre-
dictors of opsonic and antiadhesion activity. Categorical and continuous vari-
ables included in the initial model were HIV status, anemia, infant birth weight,
history of febrile symptoms within the last 7 days, sulfadoxine-pyrimethamine
treatment, malaria stage, presence of monocyte pigment, and presence of fibrin
pigment. Backwards elimination was applied to sequentially remove nonsignifi-
cant variables until a subset of wholly significant predictors remained. A variable
was considered to be significant if the P value was less than 0.05. The correlations
between the logarithms of opsonic activity or adhesion with the logarithm of
antibody levels were performed using Pearson’s product-moment correlation
with the confidence interval based on Fisher’s transformation.
RESULTS
Gender- and parity-dependent immune responses to VSA-
PAM. To validate the assays, we compared adhesion inhibition
and opsonic activity in sera obtained from sympatric males as
well as primigravid and multigravid women without HIV in-
fection. Sera from males contained very low levels of both
antiadhesion and opsonic activity, and multigravid women had
significantly higher adhesion-blocking and opsonic activities
than did primigravid women after deflating the significance
level to account for multiple comparisons (P  0.0001 and P 
0.004, respectively, by unpaired t test) (Fig. 1). There was a
similar gender- and parity-dependent increase in this cohort in
levels of antibody to VSA-PAM measured by flow cytometry,
as previously described (23; data not shown).
Relationship between total IgG to CS2 and functional anti-
body assays. We initially examined functional activity in sera
from multigravid women with malaria as these individuals
would be expected to possess the highest levels of antibody to
VSA-PAM. Moreover, multigravid women have the highest
relative risk of malaria infection associated with HIV coinfec-
tion (31). Total VSA-PAM-specific IgG (determined by flow
cytometry) correlated relatively weakly with antiadhesion ac-
tivity (r  0.33; P  0.0019) (Fig. 2A) but showed a stronger
correlation with opsonic activity (r  0.60; P  0.001) (Fig.
2B). The closer relationship between opsonic activity and total
IgG to VSA-PAM may arise because all VSA-PAM epitopes
may be targets for opsonization, whereas only a subset of
epitopes participates in adhesion.
Opsonic activity is impaired by HIV infection. Having vali-
dated and established the characteristics of our assays, we next
examined the association between HIV coinfection in multi-
gravid women with malaria and functional antibody in their
sera. Antiadhesion antibody responses did not show an asso-
ciation with HIV infection (P  0.938; mean activities of 56.0
for HIV-positive women and 56.4 for HIV-uninfected women)
(Fig. 3A), whereas HIV-infected women showed significantly
impaired opsonic activity against CS2 IE (P  0.045; mean
activities of 45.8 for HIV-positive women and 62.1 for HIV-
uninfected women) (Fig. 3B). This suggests that HIV has var-
ious effects on different aspects of anti-CS2 activity and that
HIV may significantly diminish quantities of opsonizing anti-
bodies directed against CS2 IE in multigravid women.
FIG. 1. Functional activity of antibodies to CS2-VSA is gender
specific and parity dependent in both adhesion and opsonization as-
says. A comparison of antibody responses in males (n  14), primi-
gravid HIV-uninfected women (n  44), and multigravid HIV-unin-
fected women (n  29) is shown. (A) Adhesion inhibition assay.
Horizontal bars represent means of each group. Differences between
all groups were statistically significant (P  0.0001 for all comparisons
by unpaired t test). (B) Phagocytosis assay. CS2-IE were opsonized
with patient sera and then used as targets for phagocytosis by THP1
cells. The difference in percent phagocytic index between males and
primigravid HIV-uninfected women and males and multigravid HIV-
uninfected and primigravid women versus multigravid HIV-uninfected
women was statistically significant (P  0.0001, P  0.0001, and P 
0.004, respectively, by unpaired t test).
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To further examine the relationship between antibody activ-
ity and HIV infection, we compared antiadhesion and opsonic
activities in sera from HIV-infected women with well-pre-
served CD4 T-cell counts (500 cells/l), intermediate CD4
T-cell counts (between 200 and 500 cells/l), and severe im-
munosuppression (CD4 T-cell counts of 200 cells/l) and in
sera from HIV-uninfected women. For both assays, there was
a trend of decreased activity with decreased CD4 counts, but
given the relatively low numbers in some of the groups, this
was not statistically significant (Fig. 4). Using pairwise com-
parisons, however, there was a significant difference in opsonic
activity between women with 200 CD4 T cells/l and HIV-
uninfected women (P  0.0045).
Taken together, these data suggest a significant impairment
of opsonic but not adhesion-blocking activity associated with
HIV infection in multigravid women with malaria. Multigravid
women in an area where malaria is endemic who have malaria
in their current pregnancy may be expected to have boosted
levels of antibody specific for VSA-PAM at term. The effects of
HIV coinfection on aspects of anti-VSA-PAM function may
therefore reflect an inadequate boosting of this response. It
was therefore of interest to examine opsonic activity in a co-
hort of multigravid women without current malaria, as it would
be expected that antibody levels and function in this cohort
would reflect an immunological memory of responses gener-
ated in prior pregnancies. Antibody levels are often lower in
malaria-uninfected individuals than in infected individuals. As
expected, there was a significantly lower level of anti-VSA-
PAM in both HIV-infected (n  102) and HIV-uninfected (n 
54) women without PAM than in the same cohorts of women
with malaria (P  0.0001 and P  0.0094, respectively). This
was also true for opsonic activity (P  0.0001 for both com-
parisons). Of interest, however, in our group of multigravid
women without malaria, HIV infection was not associated with
lower opsonic activity (P  0.318) (Fig. 5), suggesting that HIV
infection may selectively inhibit the increase in opsonic activity
toward VSA-PAM occurring during malaria infection.
Association of anti-VSA PAM activity with anemia. To de-
termine whether the levels of antibodies as measured with our
different assays are associated with a decreased incidence of
complications in placental malaria, we examined the relation-
ship between opsonic activity, adhesion-blocking activity, or
total IgG to VSA-PAM, maternal Hb levels, and infant birth
weight. There was no significant relationship between antibody
levels or function and birth weight (data not shown). Among
malaria-infected women, those with anemia (Hb levels of
11.0 g/dl) showed significantly lower opsonic activity than
nonanemic women (P  0.022 by one-way analysis of variance
[ANOVA]) (Fig. 6A). In pairwise comparisons, after deflating
the significance level to account for multiple comparisons, this
difference approached significance in HIV-negative women (P 
FIG. 2. Correlation between total VSA-PAM-specific IgG and ad-
hesion inhibition (A) or opsonic activity (B) in patient sera from
multigravid women with PAM. Flow cytometry was used to measure
levels of serum antibodies (Ab) specific for CS2-VSA and compared
with both antiadhesion and phagocytic activities for each serum sam-
ple. Correlations were performed on log-transformed data. A weak
correlation was seen between antibody level and percent adhesion
inhibition (Pearson’s r  0.33). A marked correlation was seen be-
tween the antibody level and percent phagocytic index (Pearson’s r 
0.60). Each point represents the mean of an experiment for a single
sample performed in triplicate and standardized to the positive control
for that individual experiment.
FIG. 3. HIV infection reduces opsonic but not antiadhesion activity
against CS2-VSA in multigravid women with PAM. Antibody function
was measured and compared between HIV-infected (n  58) (open
symbols) and HIV-uninfected (n  29) (closed symbols) women using
the adhesion inhibition (A) and opsonization (B) assays. Antiadhesion
activity for HIV-infected women was not statistically different from
that for HIV-uninfected women (P  0.938 by unpaired t test). The
opsonic activity for HIV-infected women was significantly lower than
that for HIV-uninfected women (P  0.045 by unpaired t test). Each
point represents the mean of an experiment for a single sample per-
formed in triplicate and standardized to a positive control within an
individual experiment. Horizontal bars indicate the means for each
group.
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0.03) but not in HIV-positive women (P  0.12), suggesting
that the association of anemia and low opsonic activity in these
women is not due to HIV infection. Neither adhesion-blocking
activity (P  0.81 by one-way ANOVA) (Fig. 6B) nor total IgG
to VSA-PAM (P  0.51 by one-way ANOVA) (Fig. 6C)
showed any significant association with anemia, suggesting that
opsonic activity but not antibody level or antiadhesion activity
is associated with protection from pregnancy-associated ane-
mia in this cohort. There were no significant differences in
opsonic activity or anti-VSA-PAM levels in anemic versus non-
anemic women in the cohort of women without malaria (data
not shown).
Multivariate analysis of opsonic activity in multigravid
women with malaria. Finally, we assessed HIV status, age,
infant birth weight, and maternal anemia for their association
with opsonic activity using stepwise multivariate analyses in the
cohort of multigravid women with malaria (Table 2). In the
multivariate analysis, the association of opsonic activity with
infant birth weight and maternal age was not significant. HIV
status, while significant in the univariate analysis, was no longer
significant in the multivariate model; only maternal anemia
FIG. 4. CD4 T-cell count is associated with opsonic but not anti-
adhesion activity in HIV-infected multigravid women with PAM. Mul-
tigravid women coinfected with HIV (closed symbols) were stratified
on the basis of CD4 T-cell counts into three groups, low (200 cells/
l), intermediate (200 to 500 cells/l), and well preserved (500 cells/
l). Log-transformed adhesion-blocking (A) and opsonic (B) activities
are shown for each group and compared to those for HIV-uninfected
women (open symbols). There was no difference in adhesion-blocking
activity between any of the groups (P  0.185 by one-way ANOVA).
For opsonic activity, using pairwise comparisons, only women with
CD4 T-cell counts of 200 cells/l were significantly different from
women who were HIV negative (P  0.0045 by unpaired t test).
FIG. 5. HIV infection does not affect opsonic activity in multi-
gravid pregnant women without PAM. Log opsonic activities were
compared in sera from multigravid women without PAM stratified for
HIV infection. There was no significant difference (P  0.318 by
unpaired t test) between HIV-infected (n  102) (open symbols) and
HIV-uninfected (n  54) (closed symbols) women.
FIG. 6. Opsonic but not adhesion-blocking activity or total levels of
anti-VSA-PAM is associated with protection from anemia in multi-
gravid women with PAM. Multigravid women with malaria were strat-
ified on the basis of maternal Hb levels using the clinical definitions of
anemic (Hb levels of 11 g/dl) (closed symbols) and nonanemic (Hb
levels of 11 g/dl) (open symbols) and on the basis of HIV status (HIV
infected [circles] and HIV uninfected [squares]). Data for opsonic
activity (A), adhesion-blocking activity (B), and total anti-VSA-PAM
(C) are shown. There was no difference in adhesion-blocking activity or
total anti-VSA-PAM between groups (P  0.81 and P  0.51, respec-
tively, by one-way ANOVA). There was a significant difference in
opsonic activity between groups (P  0.022 by one-way ANOVA),
which, in pairwise comparisons, approached significance (after deflat-
ing the significance level to account for multiple comparisons) for
HIV-uninfected women (P  0.03 by unpaired t test) but not HIV-
coinfected women (P  0.122 by unpaired t test).
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remained significant (P  0.007). The mean log opsonic activ-
ity of anemic women was 1.636 (standard error of the mean,
0.039), compared to 1.802 (standard error of the mean, 0.046)
for nonanemic women, which is equivalent to mean opsonic
activities of 43.21 and 63.39, respectively. Upon logistic regres-
sion, being anemic was significantly associated with a decrease
in opsonic activity of 20.14 compared to being nonanemic.
DISCUSSION
Antibody is a critical component of immunity to PAM. In
pregnant women, IgG1 and IgG3 responses to VSA-PAM de-
velop (8, 18), and total IgG to these targets has been correlated
with protection from anemia and increased birth weight (29).
Two main functions for antibody to VSA-PAM are suggested:
blockade of adhesion to tissue-specific receptors (10) and op-
sonization of IE for phagocytic clearance. Adhesion-blocking
antibodies have been associated with protection from anemia
and premature delivery (7), whereas the protective role for
opsonizing antibodies has not been explored. In the present
study, we examined the relationship between antibody levels
and function, HIV infection, and susceptibility to malaria com-
plications using sera from pregnant women with and without
HIV infection and malaria. Opsonic activity, like other mea-
sures of antibody immunity, showed gender and parity depen-
dence. Moreover, opsonic activity correlated more strongly
with total IgG levels to VSA-PAM than did the adhesion-
blocking ability, suggesting that the opsonic clearance of IE
may be a major function of antibodies generated against PAM.
In univariate analyses, among multigravid women with concur-
rent malaria, lower opsonic activity, but not adhesion-blocking
activity, was associated with anemia and HIV infection, and
opsonic activity was lowest in the most immunosuppressed
women. In multivariate analyses, maternal Hb remained sig-
nificantly associated with opsonic activity, but HIV status did
not. The strong relationship that we noted between CD4 T-cell
count and opsonizing antibody and the trend for antibody to be
lower in HIV-infected individuals across the whole cohort sug-
gest that there is a relationship between HIV-related immu-
nosuppression and opsonizing antibody, but this effect of HIV
is unlikely to be a major determinant of susceptibility to ma-
laria in pregnancy.
The strong association that we observed between anemia
and opsonic activity suggests that protection from malarial
anemia may be an important role of opsonizing antibody. In-
terestingly, in the larger group of multigravid women without
malaria, neither opsonic activity nor IgG to VSA-PAM varied
with HIV status or Hb levels. This may be because HIV infec-
tion impairs the maintenance of memory B-cell pools (17, 32)
and therefore affects primarily the increase in circulating an-
tibody levels, which follows an adaptive response to current
infection. In children, levels of antibody responses increase
during malaria infection, and antibody responses in infected
children appear to protect against subsequent clinical disease
(12). A similar interaction may be important in pregnancy, with
opsonizing antibody being protective only in the context of
present infection.
Our starting hypothesis, that HIV infection would cause a
decrease in opsonizing activity, which may explain the in-
creased susceptibility to malaria, was not confirmed. As we
previously postulated (20), it is possible that HIV exerts a
greater effect on antibody responses to neoantigens than on
existing responses, in which case the effect of HIV on opso-




Unadjusted estimate (95% CI) Adjusted estimate (95% CI)
Coefficient P value Coefficient P valuea
Total 87 100
HIV status
Positive 58 66.67 0
Negative 29 33.33 0.132 (0.003, 0.260) 0.045 NS
Age (yr)b
24 22 25.29 0
25–27 28 32.18 0.160 (0.323, 0.003) 0.055 NS
28–30 17 19.54 0.047 (0.232, 0.137) 0.611 NS
30 19 21.84 0.060 (0.240, 0.119) 0.506 NS
Unknown 1 1.15
Anemiac
No 51 58.62 0
Yes 36 41.38 0.166 (0.287, 0.046) 0.007 0.166 (0.287, 0.046) 0.007
Birth wt (g)b
2,650 21 24.14 0
2,651–3,000 23 26.44 0.005 (0.187, 0.176) 0.954 NS
3,001–3,300 18 20.69 0.064 (0.129, 0.257) 0.510 NS
3,300 15 17.24 0.061 (0.143, 0.264) 0.554 NS
Unknown 10 11.49
a NS, not significant.
b Cutoffs for age and birth weight were designed to divide the data set into four approximately equal groups.
c Anemia was defined as Hb levels of 11.0 g/dl.
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nizing activity in primigravid women should be investigated, as
VSA-PAM would be a neoantigen in these women.
Our findings differ from those reported previously by Keen
et al., who showed marked decreases in levels of opsonic ac-
tivity in plasma from 23 HIV-infected compared to 23 HIV-
uninfected multigravid Kenyan women (11). Those investiga-
tors used CD36/ murine macrophages, rather than human
THP-1 cells, in their phagocytic assays and manual counting
instead of colorimetry to determine phagocytic indices. Sam-
ples were collected after delivery, but most women did not
have placental malaria on blood film, and most of the women
had well-preserved CD4 T-cell counts. None of these differ-
ences fully explain the contrasting findings with our study. No
data were presented by Keen et al. on the anemia statuses of
the patients used in their study. The use of murine macro-
phages, as opposed to human macrophages, may also intro-
duce differences due to the different Fc	 receptors expressed
on murine cells. In this regard, Tebo et al. previously reported
that THP1 cells use both Fc	 receptors IIA and I to ingest
malaria-infected erythrocytes (30). Murine macrophages, how-
ever, lack an FcR	-independent activating Fc	 receptor equiv-
alent to human Fc	 receptor IIA. This may not be an impor-
tant difference, however, as Keen et al. reported similar
findings using human macrophages, suggesting that species
difference is not critical (11). We confirmed the expression of
both Fc	 RI and RIIA on the THP1 cells used in the present
study, but their relative importance in the uptake of CS2 IE
opsonized with patient sera was not investigated. It is possible
that HIV differentially affects phagocytosis mediated by these
two receptors (15). Further studies from areas of high HIV
endemicity will be of interest.
Our parent study was designed primarily to recruit HIV-
infected women to examine factors influencing mother-to-child
HIV transmission. HIV-uninfected women were recruited if
they had peripheral blood malaria infection, together with
matched controls for these women. The prevalence of malaria
upon peripheral blood examination was 9.5%, which is lower
than that reported in previous studies from the same site (25).
Together, these factors may have introduced biases into our
study, affecting the relationship between HIV and malarial
immunity. For example, because all HIV-1-infected women
but only HIV-uninfected women with smear-positive malaria
and their controls were recruited, the proportions of women
differed by gravidity between the HIV-1-infected and -unin-
fected groups. In the population of women screened for this
study, HIV-1 prevalence was not significantly associated with
factors that may influence malaria exposure, such as education,
residence, and employment (14). Moreover, to minimize pos-
sible confounding, we tested all available samples from our
patient groups and compared multigravid women with and
without HIV-1 separately for those with current malaria infec-
tion and those without. It may be that primigravid study par-
ticipants, who have a greater malaria risk and are more likely
to deliver infants with malaria-related low birth weight, would
show a different pattern of responses.
The role of opsonizing antibodies in facilitating the clear-
ance of IE by phagocytic cells clearly requires further study
independently of any deficiencies of such responses associated
with HIV infection. We observed a strong association between
low levels of opsonizing antibodies and maternal anemia. A
deficit in antibodies that facilitate the clearance of infected
erythrocytes may be highly relevant to the development of this
important complication of malaria. Most severe anemia occurs
in children, and the defective clearance of IE could play a
pathogenic role in its development. Assays of functional anti-
body immunity, together with examination of phagocytic cell
activity from malaria-infected individuals, may provide critical
insights into disease pathogenesis and provide useful surro-
gates of vaccine efficacy suitable for use in field studies.
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